206 related articles for article (PubMed ID: 30446458)
1. Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database.
Farber NJ; Rivera-Núñez Z; Kim S; Shinder B; Radadia K; Sterling J; Modi PK; Goyal S; Parikh R; Mayer TM; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Urol Oncol; 2019 Jan; 37(1):26-32. PubMed ID: 30446458
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of clinical nodal staging and factors associated with receipt of lymph node dissection at the time of surgery for nonmetastatic renal cell carcinoma.
Radadia KD; Rivera-Núñez Z; Kim S; Farber NJ; Sterling J; Falkiewicz M; Modi PK; Goyal S; Parikh R; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Urol Oncol; 2019 Sep; 37(9):577.e17-577.e25. PubMed ID: 31280982
[TBL] [Abstract][Full Text] [Related]
3. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
[TBL] [Abstract][Full Text] [Related]
4. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection.
Faiena I; Salmasi A; Lenis AT; Donin NM; Johnson DC; Bachour K; Drakaki A; Belldegrun AS; Pantuck AJ; Chamie K
Urol Oncol; 2018 Feb; 36(2):79.e19-79.e26. PubMed ID: 29103965
[TBL] [Abstract][Full Text] [Related]
5. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma.
Bacic J; Liu T; Thompson RH; Boorjian SA; Leibovich BC; Golijanin D; Gershman B
Urology; 2020 Jun; 140():98-106. PubMed ID: 32142726
[TBL] [Abstract][Full Text] [Related]
6. European temporal trends in the use of lymph node dissection in patients with renal cancer.
Capitanio U; Stewart GD; Larcher A; Ouzaid I; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Salagierski M; Volpe A; Mir MC; Kriegmair M; Terrone C; Brookman-May SD; Montorsi F; Klatte T;
Eur J Surg Oncol; 2017 Nov; 43(11):2184-2192. PubMed ID: 28801061
[TBL] [Abstract][Full Text] [Related]
7. Decreasing rates of lymph node dissection during radical nephrectomy for renal cell carcinoma.
Kates M; Lavery HJ; Brajtbord J; Samadi D; Palese MA
Ann Surg Oncol; 2012 Aug; 19(8):2693-9. PubMed ID: 22526899
[TBL] [Abstract][Full Text] [Related]
8. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
Mao R; Zhao H; Li K; Luo S; Turner M; Cai JQ; Blazer D
Ann Surg Oncol; 2019 Sep; 26(9):2722-2729. PubMed ID: 31209670
[TBL] [Abstract][Full Text] [Related]
10. Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration.
Chipollini J; Abel EJ; Peyton CC; Boulware DC; Karam JA; Margulis V; Master VA; Zargar-Shoshtari K; Matin SF; Sexton WJ; Raman JD; Wood CG; Spiess PE
Clin Genitourin Cancer; 2018 Apr; 16(2):e443-e450. PubMed ID: 29113770
[TBL] [Abstract][Full Text] [Related]
11. Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis.
Wei Y; Wang M; Jin Y; Zhou C; Lyu J
World J Urol; 2020 Jun; 38(6):1579-1585. PubMed ID: 31065795
[TBL] [Abstract][Full Text] [Related]
12. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031
[TBL] [Abstract][Full Text] [Related]
13. Lymph node dissection during radical nephrectomy: A Canadian multi-institutional analysis.
Kokorovic A; Breau RH; Kapoor A; Finelli A; So AI; Lavallee LT; Tanguay S; Pouliot F; Drachenberg DE; Fairey A; Lattouf JB; Kawakami J; Wood L; Mallick R; Rendon RA
Urol Oncol; 2021 Jun; 39(6):371.e17-371.e25. PubMed ID: 33785219
[TBL] [Abstract][Full Text] [Related]
14. Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
Tilki D; Chandrasekar T; Capitanio U; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Linares Espinós E; Lorentz A; Martinez-Salamanca JI; Master VA; McKiernan JM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Rodriguez-Faba O; Russo P; Scherr DS; Shariat SF; Spahn M; Terrone C; Vera-Donoso C; Zigeuner R; Libertino JA; Evans CP
Urol Oncol; 2018 Feb; 36(2):79.e11-79.e17. PubMed ID: 29129353
[TBL] [Abstract][Full Text] [Related]
15. Lymph node dissection in renal cell carcinoma.
Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
[TBL] [Abstract][Full Text] [Related]
16. The critical role of lymph node dissection in selecting high-risk nonmetastatic renal cancer candidates for adjuvant therapy after nephrectomy.
Capogrosso P; Larcher A; Nini A; Muttin F; Cianflone F; Ripa F; Briganti A; Necchi A; Montorsi F; Salonia A; Bertini R; Capitanio U
Urol Oncol; 2019 Apr; 37(4):293.e25-293.e30. PubMed ID: 30704958
[TBL] [Abstract][Full Text] [Related]
17. The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis.
Bhindi B; Wallis CJD; Boorjian SA; Thompson RH; Farrell A; Kim SP; Karam JA; Capitanio U; Golijanin D; Leibovich BC; Gershman B
BJU Int; 2018 May; 121(5):684-698. PubMed ID: 29319926
[TBL] [Abstract][Full Text] [Related]
18. Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns.
Tachibana I; Vasquez R; Mahmoud M; Kern SQ; Patel RS; King J; Adra N; Boris RS; Cary C; Rice KR
Urol Oncol; 2022 Nov; 40(11):495.e11-495.e17. PubMed ID: 36154800
[TBL] [Abstract][Full Text] [Related]
19. Influence of lymph node dissection in patients undergoing radical nephrectomy for non-metastatic renal cell carcinoma: a systematic review and meta-analysis.
Luo X; Li JX; Liu YT; Zou G; Yao WX; Qing GQ; Yang RL; Ye XY; Facchini G; Rossetti S
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6079-6090. PubMed ID: 31364109
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma.
Chapman TN; Sharma S; Zhang S; Wong MK; Kim HL
Urology; 2008 Feb; 71(2):287-91. PubMed ID: 18308105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
